Completion of a "First in Human" Clinical Phase I Study with a Therapeutic Protein Derived from CAP® Cells
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes (CAP® Cells),…
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes (CAP® Cells),…
Das Geschäft mit der Nachhaltigkeit steht im Fokus des Impulsforums ibet 2013 in Bregenz - Darf, soll oder muss sich unt…
Rentschler Biotechnologie GmbH is pleased to announce the second Laupheimer Zelltage , a biennial industrial cell cultur…